Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review

被引:0
作者
José M Olivares
Jan Sermon
Michiel Hemels
Andreas Schreiner
机构
[1] Complejo Hospitalario Universitario de Vigo,Department of Psychiatry, Hospital Meixoeiro
[2] Janssen-Cilag NV/SA,Medical and Scientific Affairs
[3] Janssen Health Economics Market Access and Reimbursement,undefined
[4] Janssen-Cilag Europe,undefined
来源
Annals of General Psychiatry | / 12卷
关键词
Relapse; Hospitalization; Schizophrenia; Definition; Adherence; Drivers;
D O I
暂无
中图分类号
学科分类号
摘要
Relapse in patients with schizophrenia has devastating repercussions, including worsening symptoms, impaired functioning, cognitive deterioration and reduced quality of life. This progressive decline exacerbates the burden of illness on patients and their families. Relapse prevention is identified as a key therapeutic aim; however, the absence of widely accepted relapse definition criteria considerably hampers achieving this goal. We conducted a literature review in order to investigate the reporting of relapses and the validity of hospitalization as a proxy for relapse in patients with schizophrenia. The primary aim was to assess the range and validity of methods used to define relapse in observational or naturalistic settings. The secondary aim was to capture information on factors that predicted or influenced the risk of relapse. A structured search of the PubMed database identified articles that discussed relapse, and hospitalization as a proxy of relapse, in patients with schizophrenia. National and international guidelines were also reviewed. Of the 150 publications and guidelines identified, 87 defined relapse and 62% of these discussed hospitalization. Where hospitalization was discussed, this was as a proxy for, or a component of, relapse in the majority of cases. However, hospitalization duration and type varied and were not always well defined. Scales were used to define relapse in 53 instances; 10 different scales were used and multiple scales often appeared within the same definition. There were 95 references to factors that may drive relapse, including non-adherence to antipsychotic medication (21/95), stress/depression (11/95) and substance abuse (9/95). Twenty-five publications discussed the potential of antipsychotic therapy to reduce relapse rates—continuous antipsychotic therapy was associated with reduced frequency and duration of hospitalization. Non-pharmacological interventions, such as psychoeducation and cognitive behavioural therapy, were also commonly reported as factors that may reduce relapse. In conclusion, this review identified numerous factors used to define relapse. Hospitalization was the factor most frequently used and represents a useful proxy for relapse when reporting in a naturalistic setting. Several factors were reported to increase the risk of relapse, and observation of these may aid the identification of at-risk patients.
引用
收藏
相关论文
共 668 条
  • [1] Jablensky A(1992)Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study Psychol Med Monogr Suppl 20 1-97
  • [2] Sartorius N(2005)World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: acute treatment of schizophrenia World J Biol Psychiatry 6 132-191
  • [3] Ernberg G(2005)Remission in schizophrenia: proposed criteria and rationale for consensus Am J Psychiatry 162 441-449
  • [4] Anker M(2006)World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia World J Biol Psychiatry 7 5-40
  • [5] Korten A(2004)Practice guideline for the treatment of patients with schizophrenia, second edition Am J Psychiatry 161 1-56
  • [6] Cooper JE(2005)Towards consensus in the long-term management of relapse prevention in schizophrenia Hum Psychopharmacol 20 175-181
  • [7] Day R(2007)Treatment strategies to prevent relapse and encourage remission J Clin Psychiatry 68 27-30
  • [8] Bertelsen A(2007)Treatment adherence and long-term outcomes CNS Spectr 12 21-26
  • [9] Falkai P(2008)The burden of schizophrenia on caregivers: a review Pharmacoeconomics 26 149-162
  • [10] Wobrock T(2009)Effectiveness of brief cognitive-behavioral therapy for schizophrenia delivered by mental health nurses: relapse and recovery at 24 months J Clin Psychiatry 70 201-207